70 mg lyophilised · blend - BPC-157 (10 mg) + GHK-Cu (50 mg) + TB-500 (10 mg)
$140.00 CAD
Glow is a combination of BPC-157, GHK-Cu, and TB-500 - three peptides studied for tissue repair and skin health. It is used in research that looks at recovery and skin-remodelling activity when these compounds are combined.
For laboratory and research use only - not for human consumption.
Checking the live COA archive for the newest lot documentation.
Use the verification archive to select a peptide name and review all published lot records alphabetically.
View previous lab resultsGlow is a three-peptide blend combining BPC-157, GHK-Cu, and TB-500 - three of the most-studied tissue-repair and skin-research compounds - in a single vial.
Research interest centres on combining peptides associated with angiogenesis (new blood-vessel growth), extracellular-matrix and skin remodelling, and cell migration, to study recovery- and skin-focused endpoints together. The underlying evidence is the preclinical literature of the individual components.
The components contribute complementary activities - BPC-157 (angiogenesis and cytoprotection), GHK-Cu (matrix remodelling and copper delivery), and TB-500 (actin regulation and cell migration, i.e. helping cells move to repair sites).
Each component is a research compound, not an approved medicine; BPC-157, TB-500, and GHK-Cu are all part of the FDA’s 2026-2027 peptide-compounding review in the U.S. This does not change the blend’s research-use status in Canada - not for human consumption.
A single vial containing a 70 mg blend (BPC-157 10 mg, GHK-Cu 50 mg, TB-500 10 mg) as a lyophilised powder.
